Avidity begins Cohort C enrollment in FORTITUDE trial
Posted on October 30th, 202410/30/24
Avidity begins Cohort C enrollment in FORTITUDE trial Avidity Biosciences has begun enrollment of Cohort C of the Phase 1/2 FORTITUDE™ clinical trial. Below is Avidity’s letter to the FSHD […]